• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Drug-Device Combinations

Lyra Therapeutics appoints new chief medical officer

July 5, 2022 By Sean Whooley

Lyra Therapeutics chief medical officer Richard Neiman

Lyra Therapeutics (Nasdaq:LYRA) announced today that it appointed Dr. Richard Nieman as its new chief medical officer (CMO). Nieman’s appointment as CMO of Lyra, which develops the XTreo — a platform for enabling precise, sustained and local delivery of medications to the ear, nose and throat (ENT) passages and other diseased tissues — will be […]

Filed Under: Business/Financial News, Drug-Device Combinations, Featured, Implants, Otolaryngology Ear, Nose & Throat, Personnel, Pharmaceuticals, Respiratory Tagged With: Lyra Therapeutics, Personnel, Personnel Moves

FDA lifts hold on Vertex’s insulin-producing cell therapy for diabetes

July 5, 2022 By Sean Whooley

Vertex Pharmaceuticals

Vertex Pharmaceuticals (Nasdaq:VRTX) announced today that the FDA lifted the clinical hold placed on the Phase 1/2 trial of VX-880. Boston-based Vertex designed VX-880 as a stem cell-derived fully differentiated pancreatic islet cell replacement therapy for people with type 1 diabetes with impaired hypoglycemic awareness and severe hypoglycemia. It could potentially restore the body’s ability […]

Filed Under: Clinical Trials, Diabetes, Drug-Device Combinations, Featured, Food & Drug Administration (FDA), Pharmaceuticals Tagged With: Vertex Pharmaceuticals

Retractable Technologies declares dividends

July 1, 2022 By Sean Whooley

Retractable Technologies

Retractable Technologies (NYSE:RVP) announced that its board of directors declared dividends to holders of its convertible preferred stock. The dividends declared to holders of Retractable Technologies’ Series II Class B and Series III Class B convertible preferred stock totals amounts of $39,050 and $19,061.25, respectively. Dividends have accrued a $1 per share per annum and […]

Filed Under: Business/Financial News, Drug-Device Combinations, Wall Street Beat Tagged With: Retractable Technologies

Teva appoints former Vertex exec as new head of R&D, CMO

July 1, 2022 By Sean Whooley

Teva Pharmaceuticals Global R&D Chief Medical Officer CMO Eric A. Hughes

Teva Pharmaceuticals (NYSE:TEVA) announced today that it appointed Dr. Eric A. Hughes as VP of global R&D and chief medical officer. Hughes’ employment becomes effective Aug. 1, 2022, and he will be based out of Tel Aviv, Israel-based Teva’s U.S. headquarters in Parsippany, New Jersey. The company develops generic and specialty medicines, including inhalation solutions. […]

Filed Under: Auto-injectors, Business/Financial News, Drug-Device Combinations, Featured, Personnel, Pharmaceuticals, Technology Tagged With: Personnel, Personnel Moves, Teva, Teva Pharmaceuticals

West Pharmaceutical Services debuts new needle syringe system

July 1, 2022 By Sean Whooley

West Pharmaceutical Services Daikyo Crystal Zenith Insert Needle Syringe System

West Pharmaceutical Services (NYSE:WST) announced the recent unveiling of its Daikyo Crystal Zenith needle syringe system. Exton, Pennsylvania–based West designed the Daikyo Crystal Zenith 2.25mL insert needle syringe system as a technologically advanced cyclic olefin polymer containment and delivery system. It’s meant to offer an alternative to glass, mitigating the risk of breakage and reducing […]

Filed Under: Business/Financial News, Drug-Device Combinations, Pharmaceuticals Tagged With: West Pharmaceutical, West Pharmaceutical Services

CeQur is launching a discreet, convenient ‘wearable insulin pen’

July 1, 2022 By Sean Whooley

CeQur Simplicity

CeQur designed its Simplicity device to make insulin delivery as seamless as possible for people with diabetes. When it comes to managing diabetes, CeQur wants to make insulin therapy as convenient as possible. For those who prefer to manage their own insulin delivery, the Simplicity device might just do exactly that. Simplicity, a wearable, disposable […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Technology Tagged With: cequr

NovaXS unveils prototype for smart, needle-free drug delivery device

June 28, 2022 By Sean Whooley

NovaXS Smart Injector

NovaXS Biotech announced that it unveiled the new prototype for its needle-free injection therapy smart medical device. Formed at the University of California, Berkeley, NovaXS designed its patent-pending Telosis technology to administer a narrow stream of medication without a needle in 0.3 seconds and to analyze injection data to allow for smarter health decisions. The […]

Filed Under: Auto-injectors, Business/Financial News, Drug-Device Combinations, Featured, Women's Health Tagged With: NovaXS

Advanced NanoTherapies closes $7.2M Series A for drug-coated balloon

June 28, 2022 By Sean Whooley

Advanced NanoTherapies Sirplux Duo

Advanced NanoTherapies announced today that it closed an oversubscribed Series A equity financing round. Los Gatos, California-based Advanced NanoTherapies, which develops the SirPlux Duo drug-coated balloon (DCB) for treating de novo coronary artery disease (CAD) lesions, has now raised $12.5 million in total since September 2020. The company said in a news release that the […]

Filed Under: Business/Financial News, Cardiovascular, Drug-Device Combinations, Featured, Funding Roundup, Pharmaceuticals, Vascular Tagged With: Advanced NanoTherapies

Virpax to pursue over-the-counter pathway for topical spray treatment for osteoarthritis pain

June 27, 2022 By Sean Whooley

Virpax

Virpax Pharmaceuticals (Nasdaq:VRPX) announced today that it will pursue a direct to over-the-counter (OTC) regular pathway for Epoladerm. Berwyn, Pennsylvania–based Virpax designed the Epoladerm investigational pre-filled topical spray analgesic product for the non-addictive management of chronic pain associated with osteoarthritis (OA) of the knee. According to a news release, the company expects the direct to […]

Filed Under: Business/Financial News, Drug-Device Combinations, Featured, Food & Drug Administration (FDA), Pain Management, Pharmaceuticals, Regulatory/Compliance Tagged With: Virpax Pharmaceuticals

Inovio names new chief medical officer

June 27, 2022 By Sean Whooley

Inovio Pharmaceuticals

Inovio (Nasdaq:INO) announced today that it appointed Dr. Michael Sumner as its new chief medical officer (CMO). Sumner will oversee Inovio’s clinical-stage pipeline of DNA medicines, global clinical development, clinical operations and biostatistics efforts, along with regulatory affairs, pharmacovigilance and medical affairs. He will also serve on the company’s executive leadership team and report to […]

Filed Under: Auto-injectors, Business/Financial News, Drug-Device Combinations, Featured, Oncology, Personnel, Pharmaceuticals Tagged With: Inovio Pharmaceuticals, Personnel, Personnel Moves

  • Go to page 1
  • Go to page 2
  • Go to page 3
  • Interim pages omitted …
  • Go to page 247
  • Go to Next Page »

Primary Sidebar

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Drug Delivery Business News in a minute? We Deliver!
Drug Delivery Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Signup for the newsletter

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing & Extrusion
Medical Design & Outsourcing
MedTech 100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Souring
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts
Add us on FacebookFollow us on TwitterConnect with us on LinkedIn

Copyright © 2022 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS